Now I have a good sense of the calibration anchors. Let me think about where this paper sits.

**MAP (6.33)**: A method paper with a novel Pareto-front approach, but the method is somewhat incremental — it's about hyperparameter selection for Task Arithmetic. Weaknesses include: doesn't test generalization, limited applicability to other methods, presentation issues. This paper is stronger because it diagnoses a real optimization pathology (norm inflation), has comprehensive benchmarks across multiple architectures/tasks/modalities, and demonstrates consistent gains.

**MEGA-Bench (7.00)**: Pure benchmark paper (no method contribution), with 500+ tasks, 8K samples, 40+ metrics. Weaknesses: taxonomy rationale unclear, huge cost/complexity, limited generalizability. This paper has a benchmark AND a method, making it a dual contribution.

**What Matters for Model Merging at Scale (5.33)**: Pure empirical study with limited architectures (only PaLM), no theoretical analysis, no method contribution, only 4 merging methods, text-only. This paper is substantially stronger — multi-architecture, 10 methods, theory, a novel algorithm.

Comparing this paper against these: The paper's strengths are the multi-dimensional benchmark + a novel method with mechanistic diagnosis. The weaknesses I identified (loose theorem-method connection, misleading cost comparison, limited modality evaluation) are real but addressable. This paper is more substantial than MAP (6.33) — it has a broader benchmark and a more principled method. It's comparable to MEGA-Bench (7.00) in terms of benchmark comprehensiveness, but adds a method contribution that MEGA-Bench lacks. I'd place it between MAP and MEGA-Bench, perhaps around 6.5–7.0, but the dual contribution (benchmark + method) and the empirical thoroughness push it toward the higher end.

Let me think more carefully. The weaknesses I identified:
1. **Theorem-method connection is loose** (Major): The theorem explains merging performance but doesn't directly motivate OptMerge components. This is a valid weakness but not fatal — it's a framing issue.
2. **Cost comparison ignores expert training** (Major): This is a real issue that could be addressed in rebuttal.
3. **Limited modality merging evaluation** (Minor): Only 2 datasets for modality merging.
4. **Missing confidence intervals** (Minor): Standard in this field.

These are mostly addressable. The core contributions — benchmark + method — are solid. I